ADTX: Aditxt Inc. Sotuvga nisbatan narx
Aditxt kompaniyasining autoimmun patologiyalar diagnostikasi va terapiyasi o'rtasidagi diversifikatsiyasi ushbu tendentsiyani belgilaydi, P/S tarixi esa qiymat 1017.10 darajasida qolganini ko'rsatadi. Ushbu narx harakati AditxtScore tizimining joriy etilishi va laboratoriya tarmog'ining kengayishini aks ettiradi, biroq patent himoyasi va FDA talablari moliyaviy beqarorlik bilan muvozanatlashgan holda, biznesning bozor qiymatida sezilarli nomutanosiblikni yuzaga keltirmoqda.
Aditxt (ADTX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati koeffitsiyenti Aditxt|ADTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati aditxt.com|ADTX - Kompaniyaning umumiy qarzi|Qarzning balans qiymatiga nisbati Aditxt Corp|ADTX - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar miqdori Aditxt|Tezkor likvidlik koeffitsiyenti aditxt.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
ADTX - Sof foyda|Sof foyda prognozi Aditxt|ADTX - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati aditxt.com|ADTX - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Aditxt Corp|ADTX - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bitta aksiya uchun foyda Aditxt|ADTX - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi aditxt.com|ADTX - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Aditxt
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning jamlanma tahliliyoti:Aditxt Inc. (ADTX)
Aditxt kompaniyasining AQSh ichki bozoridagi barqaror faoliyati va ishlanmalarining gumanitar maqsadli holati tashqi xatarlarni minimallashtirib, operatsion chidamlilikni ta'minlaydi. P/S koeffitsiyentining tebranishlarini tahlil qilish orqali investor bozor kapitalizatsiyasi va daromadlar o'rtasidagi bog'liqlikni baholaydi, bu esa aktiv uchun haqiqiy savdolarga nisbatan to'lovning ortiqchalik darajasini aniqlash va kotirovkalarning uzoq muddatli fundamental barqarorligini tasdiqlash imkonini beradi.
Aditxt kimlar bilan raqobatlashadi
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA Bio - P/S multiplikatori|PTGX - P/S multiplikatori|IMVT: P/S multiplikatori|Kapitalizatsiya va daromad nisbati KNSA|GRFS (Grifols) - P/S multiplikatori|Adaptive Biotech (ADPT) - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati CLDX (Celldex)|Kapitalizatsiyaning sotish hajmiga nisbati AUPH|BioCryst - Kapitalizatsiyaning daromadga nisbati|VERA: Kapitalizatsiya va daromad nisbati|DNTH: Kapitalizatsiyaning daromadga nisbati|Pharvaris NV - Kapitalizatsiyaning sotish hajmiga nisbati|ABCL: P/S multiplikatori|Tourmaline (TRML) - P/S multiplikatori|PGEN (Precigen, Inc.) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati PHAR (pharming.com)|Kapitalizatsiyaning daromadga nisbati NKTR (Nektar Therapeutics Inc.)|Kapitalizatsiyaning sotish hajmiga nisbati UPB|Zenas Biopharma, Inc. - Kapitalizatsiyaning daromadga nisbati|IMNM: Kapitalizatsiya va daromad nisbati|GOSS - Narxning daromadga nisbati|Narxning sotuvga nisbati KALV|SEPN: P/S multiplikatori|Pieris Pharma - Bozor kapitallashuvining daromadga nisbati|SVRA (Savara Corp) - P/S multiplikatori|P/S multiplikatori Rigel Corp|Narxning daromadga nisbati AnaptysBio, Inc. (ANAB)|ATXS (astriatx.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati enGene ENGN|RAPT - Kapitalizatsiyaning daromadga nisbati|Aerovate - P/S multiplikatori|ACRS - P/S multiplikatori|KYTX (Kyverna Therapeutics) - Kapitalizatsiyaning daromadga nisbati|tizianalifesciences.com - Bozor kapitallashuvining daromadga nisbati|CABA (Cabaletta Bio) - P/S multiplikatori|Ventyx Biosciences Inc. (VTYX) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Theratechnologies Inc (THTX)|Kapitalizatsiyaning daromadga nisbati Avalo Therapeutics Inc AVTX|Narxning daromadga nisbati Eledon Pharmaceuticals ELDN|AGEN - Kapitalizatsiyaning daromadga nisbati|CLYM: Kapitalizatsiyaning daromadga nisbati|ZURA - P/S multiplikatori|aTyr (ATYR) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati ADAG|IMA (ImageneBio) - P/S multiplikatori|Sotuvga nisbatan narx Shattuck Therapeutics STTK|P/S multiplikatori EQ|P/S multiplikatori connectbiopharm.com (CNTB)|P/S multiplikatori IMUX (Immunic)|ATRA: Kapitalizatsiya va daromad nisbati|InflaRx GmbH - P/S multiplikatori|Narx/daromad koeffitsiyenti x4pharma.com XFOR|ACET (adicetbio.com) - Kapitalizatsiyaning daromadga nisbati|CELU: Kapitalizatsiyaning sotish hajmiga nisbati|Kapitalizatsiyaning daromadga nisbati INMB|Kapitalizatsiya va daromad nisbati BRNS (Barinthus Biotherapeutics Corp)|Kapitalizatsiyaning daromadga nisbati KZR (Kezar Life Sciences)|Kapitalizatsiyaning sotish hajmiga nisbati SABS|P/S multiplikatori AKTX (Akari Therapeutics Plc)|P/S multiplikatori Enlivex Therapeutics Ltd ENLV|Q32 Bio Corp - P/S multiplikatori|GOVX (GeoVax Corp) - Kapitalizatsiya va daromad nisbati|EDSA (Edesa Biotech, Inc.) - Kapitalizatsiyaning daromadga nisbati|IBIO: Kapitalizatsiyaning sotish hajmiga nisbati|Kapitalizatsiyaning daromadga nisbati CARM|Kapitalizatsiya va daromad nisbati XTLB (XTL Biopharmaceuticals Ltd)|Narxning daromadga nisbati Bolt Biotherapeutics (BOLT)|HCWB: Narxning sotuvga nisbati|P/S multiplikatori APVO (Aptevo Therapeutics Inc.)|Bozor kapitallashuvining daromadga nisbati AIM|GRI Bio - P/S multiplikatori|XRTX - P/S multiplikatori|ReShape Lifesciences (HIND) - Narxning daromadga nisbati|Revelation Biosciences Corp - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Indaptus Therapeutics|Kapitalizatsiyaning daromadga nisbati scinai.com (SCNI)|P/S multiplikatori CALI|P/S multiplikatori affimed.com (AFMD)|Allakos - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati HOOK|IGM Bio - P/S multiplikatori|Narx/daromad koeffitsiyenti iteostherapeutics.com ITOS|Ocean Biomedical (OCEA) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati TC BioPharm (Holdings) Plc|Narxning daromadga nisbati Third Harmonic Bio, Inc
